Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | HRH1 | P35367 | 2/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.63 |
| ▸ | TBXAS1 | P24557 | 7/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.58 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.57 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6114843 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL6115248 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL6114977 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25380936 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL6115279 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25381172 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25382598 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25381701 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| Bromide SCHEMBL15822430 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL919570 | 0.98 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118834490-A | Photo-crosslinkable perfluorinated ion membrane and preparation method thereof | 上海交通大学 | 2024-10-25 | — | — | CN | claimed |
| CN-107602452-B | Synthetic method of 3-acyl pyridine compound | 河南师范大学 | 2020-02-21 | — | — | CN | claimed |
| US-10544265-B2 | Thermoset polymers having a triazine network obtained by reaction of cyanate esters with dicyanamide room temperature ionic liquids | DREXEL UNIVERSITY (US) | 2020-01-28 | — | — | US | claimed |
| US-20190330753-A1 | NICKEL (ALLOY) ELECTROPLATING SOLUTION | JAPAN PURE CHEMICAL CO., LTD. (JP) | 2019-10-31 | — | — | US | claimed |
| US-20180044473-A1 | THERMOSET POLYMERS HAVING A TRIAZINE NETWORK OBTAINED BY REACTION OF CYANATE ESTERS WITH DICYANAMIDE ROOM TEMPERATURE IONIC LIQUIDS | DREXEL UNIVERSITY (US) | 2018-02-15 | — | — | US | claimed |
| CN-107112576-A | Electrolyte for rechargeable electrochemical cells | EOS能源储存有限责任公司 | 2017-08-29 | — | — | CN | claimed |
| WO-2016123458-A1 | THERMOSET POLYMERS HAVING A TRIAZINE NETWORK OBTAINED BY REACTION OF CYANATE ESTERS WITH DICYANAMIDE ROOM TEMPERATURE IONIC LIQUIDS | DREXEL UNIVERSITY (US) | 2016-08-04 | — | — | WO | claimed |
| CN-104361997-A | DSC battery manufacturing electrolyte solution | UNIV ZHEJIANG SCIENCE & TECH | 2015-02-18 | — | — | CN | claimed |
| CN-101630593-B | Electrolyte solution and application of same in dye-sensitized solar battery | CHINESE ACAD PHYSICS INST | 2011-05-04 | — | — | CN | claimed |
| CN-101630593-A | Electrolyte solution and application of same in dye-sensitized solar battery | CHINESE ACAD PHYSICS INST | 2010-01-20 | — | — | CN | claimed |
| EP-4672982-A1 | PROCESS FOR PREPARING A FLAVOR COMPOSITION | Firmenich SA (CH) | 2026-01-07 | — | — | EP | disclosed |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-17 | — | — | US | disclosed |
| US-12195643-B2 | Adhesive film for polarizing plate, polarizing plate comprising the same and optical display apparatus comprising the same | SAMSUNG SDI CO., LTD. (KR) | 2025-01-14 | — | — | US | disclosed |
| WO-2024252982-A1 | FRAGRANCE COMPOSITION | 高砂香料工業株式会社 | 2024-12-12 | — | — | WO | disclosed |
| CN-118834490-A | Photo-crosslinkable perfluorinated ion membrane and preparation method thereof | 上海交通大学 | 2024-10-25 | — | — | CN | disclosed |
| US-4431812-A | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1984-02-14 | — | — | US | disclosed |
| EP-0069330-A1 | Pyridine carbinols, process for their preparation and fungicides containing them | BASF Aktiengesellschaft (DE) | 1983-01-12 | — | — | EP | disclosed |
| US-4021428-A | 4-Piperidino-5-oxo-2-pyrazolines | FUJI PHOTO FILM CO., LTD. (JA) | 1977-05-03 | — | — | US | disclosed |
| US-4001257-A | OXIDATION, NITRIC ACID | NIPPON SODA COMPANY LIMITED (JA) | 1977-01-04 | — | — | US | disclosed |
| US-3956339-A | 4-Pyridinio-5-pyrazolone salts, process for their preparation and their use | FUJI PHOTO FILM CO., LTD. (JA) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KDM2B, O60361, IDH3B | TDP1 2610/4885L3MBTL1 3595/4885HRH1 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.